| Mon, Feb 8, 2010 | | • | Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Mon, Feb 8)
| | Sat, Feb 6, 2010 | | • | MYRIAD GENETICS INC Financials
EDGAR Online Financials (Sat, Feb 6)
| | Thu, Feb 4, 2010 | | • | My Favorite Investor
at Motley Fool (Thu, Feb 4)
| | • | 4-Star Stocks Poised to Pop: Myriad Genetics
at Motley Fool (Thu, Feb 4)
| | Wed, Feb 3, 2010 | | • | Biotech Stocks: Pfizer leads drug stocks south
at MarketWatch (Wed, Feb 3)
| | • | New Star Analyst Rankings for Myriad Genetics, Inc.
StarMine (Wed, Feb 3)
| | • | Myriad Surpasses Zacks Estimate
Zacks.com (Wed, Feb 3)
| | • | MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Feb 3)
| | Tue, Feb 2, 2010 | | • | Myriad Genetics Inc. F2Q10 Earnings Conference Call
at Seeking Alpha (Tue, Feb 2)
| | • | Judge hears arguments over rights to gene patents
AP (Tue, Feb 2)
| | • | Myriad Genetics 2Q profit rises 67 percent
AP (Tue, Feb 2)
| | • | Myriad Genetics says lab unit president retiring
AP (Tue, Feb 2)
| | • | Myriad Genetics board member steps down
AP (Tue, Feb 2)
| | • | UPDATE - Myriad Genetics Q2 profit tops estimates, shares rise
at Reuters (Tue, Feb 2)
| | • | MYRIAD GENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financi
EDGAR Online (Tue, Feb 2)
| | • | Myriad Genetics Reports Financial Results for Fiscal 2010 Second Quarter
GlobeNewswire (Tue, Feb 2)
| | • | U.S. rights group argues against human gene patent
at Reuters (Tue, Feb 2)
| | • | Shaking Up the Biotech Industry
at Motley Fool (Tue, Feb 2)
| | • | Q2 2010 Myriad Genetics Earnings Release - After Market Close
CCBN (Tue, Feb 2)
| | Tue, Jan 26, 2010 | | • | Myriad Genetics Second Quarter Fiscal 2010 Financial Results Call scheduled for Tue, Feb 2
Shareholder.com (Tue, Jan 26)
|
Add MYGN News to My Yahoo!:
 
| |
|
1.52% Nasdaq 
0.22 (1.02%) 
Headlines
